Just Announced
APAPP
ACE App
Program Overview
The joint providership of Medical Education Resources (MER), Association of Pulmonary Advanced Practice Providers (APAPP), Cardiology Advanced Practice Providers (CAPP), and Rheumatology Advanced Practice Providers (RhAPP)
presents Bridging Specialties in ILD: A Multidisciplinary Bootcamp Series for Early Recognition and Targeted Treatment. This educational activity will deliver a high-impact, clinically grounded update on the evolving science and real-world management of interstitial lung disease (ILD).
Target Audience
This activity has been designed to meet the educational needs of nurse practitioners, physician assistants/associates, and nurses who are currently managing and treating patients with ILD.
Faculty
John Giacona, PhD, PA-C, CHC
University of Texas Southwestern Medical Center
Dallas, TX
Jessica Glennie, CNP
Cleveland Clinic
Cleveland, OH
Amanda Mixon, PA-C
UCHealth
Rheumatology Clinic
Fort Collins, CO
David Smith, MD
Louisiana State University
New Orleans, LA
Educational Objectives
Upon completion of this educational activity, participants should be able to:
-
Recognize key clinical features and risk factors suggestive of ILD across rheumatologic, pulmonary, and cardiologic settings.
-
Evaluate current treatment strategies for ILD, with emphasis on the role of antifibrotic therapy
and emerging evidence.
-
Interpret pulmonary function test (PFT) and high-resolution computed tomography (HRCT) findings to support timely and accurate ILD diagnosis.
-
Apply multidisciplinary decision-making principles to ILD patient cases using relevant clinical guidelines
and real-world scenarios.
Thursday, June 18, 2026 • 3:00–5:00 PM
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER), Association of Pulmonary Advanced Practice Providers, Cardiology Advanced Practice Providers, and Rheumatology Advanced Practice Providers. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Medical Education Resources designates this live activity for a maximum of 2.0 ANCC contact hours, which will include pharmacology hours.
Disclosures – Planning Committee & Faculty Disclosures
-
Disclosures will be provided in the presentation.
Disclosure of Relevant Financial Relationships
Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER, Association of Pulmonary Advanced Practice Providers, Cardiology Advanced Practice Providers, and Rheumatology Advanced Practice Providers planners have no relevant financial relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Association of Pulmonary Advanced Practice Providers, Cardiology Advanced Practice Providers, Rheumatology Advanced Practice Providers, and/or United Therapeutics. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee Information
There is no fee for this activity.
Jointly provided by Medical Education Resources, the Association of Pulmonary Advanced Practice Providers, Cardiology Advanced Practice Providers, and Rheumatology Advanced Practice Providers.
Supported by an educational grant from United Therapeutics.